Retroviral vectors (RVs) have been used for stable gene transfer into mammalian cells for more than 20 years. They’re relatively simple genome and structure are easy to use and are relatively safe for in vivo applications. Currently, they have also been used in alternative efforts to enhance the body's own immune response to tumors; this treatment involves reinjecting tumor cells that have been UV irradiated, genetically manipulated, or admixed with non-specific adjuvants.
As a CRO, CRDMO, Esco Aster provides viral vector production services in varying grades--research/preclinical, clinical, and commercial, respectively. Choosing and producing the best viral vectors to be used for your desired applications can be difficult, but we are here to help every step of the way!
Research / Preclinical Grade
Clinical Grade
Commercial-Grade
Esco Aster’s research-grade retrovirus production service lets you choose from multiple expression plasmid vectors depending on the expression type you desire:
Retroviral vectors transduce a wide range of hard-to-infect dividing cells and integrate into the host genome, which makes them ideal for long-term, stable expression of your transgene.
As the number and variety of planned CAR-T and gene therapy trials increases with each year, the need for commercial-grade retrovirus also continues to grow. Esco Aster is here to help you choose the best possible options for a patient-ready clinical trial material.
Esco Aster has the experience and dedication to the standards that you need in order to scale up your retrovirus gene therapy project. There are multiple courses of action for commercial-grade retroviral vector manufacturing, so we offer the flexibility and expertise to help you decide which process will best meet your custom-specific needs.